How CDMOs Are Evolving To Serve A Diverse And Emerging CGT Market

This segment of Driving Efficiency, Reducing Costs in Multi-Modal CGT Manufacturing featuring expert panelists Steve Awad, Principal Director, Supply Chain & Industry X — Life Sciences, Accenture, and Michael Blackton, MBA, VP, Manufacturing and Supply at Ocugen, explored how the CDMO landscape is adapting to support the growing diversity of CGT modalities, particularly for small and mid-sized developers that often lack in-house capabilities. Both experts noted a clear shift toward full-service offerings, which span process development, analytics, GMP manufacturing, regulatory support, supply chain, and even custom software. While consolidation across the CDMO sector is accelerating, specialization remains critical due to the scientific, regulatory, and operational complexity of CGT, especially in early-stage programs.